Literature DB >> 8426106

Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11.1 gene product.

Z Feng1, R N Hoffmann, R S Nussenzweig, M Tsuji, H Fujioka, M Aikawa, T H Lensen, T Ponnudurai, L G Pologe.   

Abstract

Monoclonal antibodies (mAb) have been raised against Plasmodium falciparum gametocyte stage protein extracts, in an effort to identify novel parasite antigens that might mediate malaria transmission-blocking immunity. mAb 1A1 identified Pfs2400, a sexual stage-specific antigen of greater than 2 megadaltons, that is associated with the outer leaflet of the parasitophorous vacuole membrane in mature circulating gametocyte-infected red blood cells. Upon induction of gametogenesis, Pfs2400 partitions between the gamete plasmalemma and the degenerating erythrocyte membrane. The antigen is no longer detectable in the fully emerged gamete. mAb 1A1 dramatically reduces the number of oocysts formed in P. falciparum gametocyte-fed mosquitoes. The cognate antigen is probably the product of the Pf11.1 gene (Scherf et al. 1988. EMBO [Eur. Mol. Biol. Organ.]J. 7:1129) on the basis that a peptide composed of two copies of the degenerate nine amino acid repeat sequence in the Pf11.1 protein, can inhibit binding of mAb1A1 to the native antigen. The mechanism of transmission inhibition mediated by the Pfs2400 is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426106      PMCID: PMC2190917          DOI: 10.1084/jem.177.2.273

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum.

Authors:  D C Kaslow; I A Quakyi; D B Keister
Journal:  Mol Biochem Parasitol       Date:  1989-01-01       Impact factor: 1.759

2.  Movement of a falciparum malaria protein through the erythrocyte cytoplasm to the erythrocyte membrane is associated with lysis of the erythrocyte and release of gametes.

Authors:  I A Quakyi; Y Matsumoto; R Carter; R Udomsangpetch; A Sjolander; K Berzins; P Perlmann; M Aikawa; L H Miller
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 3.  Current studies related to the development of transmission-blocking malaria vaccines: a review.

Authors:  J H Meuwissen
Journal:  Trans R Soc Trop Med Hyg       Date:  1989       Impact factor: 2.184

Review 4.  Plasmodium vivax malaria: parasite biology defines potential targets for vaccine development.

Authors:  P H David; H A del Portillo; K N Mendis
Journal:  Biol Cell       Date:  1988       Impact factor: 4.458

5.  Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens.

Authors:  I A Quakyi; L N Otoo; D Pombo; L Y Sugars; A Menon; A S De Groot; A Johnson; D Alling; L H Miller; M F Good
Journal:  Am J Trop Med Hyg       Date:  1989-08       Impact factor: 2.345

6.  Plasmodium falciparum: an abundant stage-specific protein expressed during early gametocyte development.

Authors:  R Carter; P M Graves; A Creasey; K Byrne; D Read; P Alano; B Fenton
Journal:  Exp Parasitol       Date:  1989-08       Impact factor: 2.011

7.  Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera.

Authors:  P M Graves; R Carter; T R Burkot; I A Quakyi; N Kumar
Journal:  Parasite Immunol       Date:  1988-03       Impact factor: 2.280

8.  Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens.

Authors:  R Udomsangpetch; J Carlsson; B Wåhlin; G Holmquist; L S Ozaki; A Scherf; D Mattei; O Mercereau-Puijalon; S Uni; M Aikawa
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

9.  The 11-1 gene of Plasmodium falciparum codes for distinct fast evolving repeats.

Authors:  A Scherf; C Hilbich; K Sieg; D Mattei; O Mercereau-Puijalon; B Müller-Hill
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

10.  Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies.

Authors:  R Carter; P M Graves; I A Quakyi; M F Good
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Transmission-Blocking Vaccines: Old Friends and New Prospects.

Authors:  Festus K Acquah; Joshua Adjah; Kim C Williamson; Linda E Amoah
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Genetic restriction and specificity of the immune response in mice to fusion proteins containing repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.

Authors:  A Sjölander; R Andersson; M Hansson; K Berzins; P Perlmann
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

3.  Plasmodium falciparum sexual parasites develop in human erythroblasts and affect erythropoiesis.

Authors:  Gaëlle Neveu; Cyrielle Richard; Florian Dupuy; Prativa Behera; Fiona Volpe; Pradeep Annamalai Subramani; Benjamin Marcel-Zerrougui; Patrice Vallin; Muriel Andrieu; Aruna Mukti Minz; Nabih Azar; Rafael M Martins; Audrey Lorthiois; Florence Gazeau; José-Juan Lopez-Rubio; Dominique Mazier; Amanda K A Silva; Sanghamitra Satpathi; Samuel C Wassmer; Frédérique Verdier; Catherine Lavazec
Journal:  Blood       Date:  2020-09-17       Impact factor: 22.113

4.  Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine Candidates.

Authors:  Roos M de Jong; Susheel K Singh; Karina Teelen; Marga van de Vegte-Bolmer; Geert-Jan van Gemert; Will J R Stone; Emily Locke; Jordan Plieskatt; Michael Theisen; Teun Bousema; Matthijs M Jore
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

5.  Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.

Authors:  Will J R Stone; Joseph J Campo; André Lin Ouédraogo; Lisette Meerstein-Kessel; Isabelle Morlais; Dari Da; Anna Cohuet; Sandrine Nsango; Colin J Sutherland; Marga van de Vegte-Bolmer; Rianne Siebelink-Stoter; Geert-Jan van Gemert; Wouter Graumans; Kjerstin Lanke; Adam D Shandling; Jozelyn V Pablo; Andy A Teng; Sophie Jones; Roos M de Jong; Amanda Fabra-García; John Bradley; Will Roeffen; Edwin Lasonder; Giuliana Gremo; Evelin Schwarzer; Chris J Janse; Susheel K Singh; Michael Theisen; Phil Felgner; Matthias Marti; Chris Drakeley; Robert Sauerwein; Teun Bousema; Matthijs M Jore
Journal:  Nat Commun       Date:  2018-02-08       Impact factor: 14.919

Review 6.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.